United States Biotechnology & Medical Research

Galecto Inc (GLTO)

Track

Track

Galecto Inc. experienced four insider trading transactions over the past ninety days, totaling approximately $449,605 in sales. Key officers, including Lori Firmani and Garrett Winslow, executed these disposals. No purchase activity occurred during this period. These divestments follow the company's most recent November 2025 results financiers report.
Ticker: GLTO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Galecto Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
Firmani Lori Officer Officer
Transaction date
Proposed sale
Price
160.85
Quantity 22,929
Value US$3,767,681
1.7
Winslow Garrett General Counsel Officer
Transaction date
Sale
Price
404.16
Quantity 28,644 -11.9%
Value US$4,525,686
2.2
Firmani Lori Officer Officer
Transaction date
Proposed sale
Price
405.04
Quantity 78,895
Value US$2,324,236
2.2
Firmani Lori Officer Officer
Transaction date
Proposed sale
Price
25.36
Quantity 7,615
Value US$193,140
1.3
Schambye Hans T. Chief Executive Officer Executive Director
Transaction date
Sale
Price
21.38
Quantity 700 -13.0%
Value US$14,966
2.2
Firmani Lori Chief Financial Officer Officer
Transaction date
Sale
Price
21.41
Quantity 135 -12.7%
Value US$2,890
1.7
Winslow Garrett General Counsel Officer
Transaction date
Sale
Price
21.38
Quantity 255 -12.1%
Value US$5,452
1.3
Schambye Hans T. Chief Executive Officer Executive Director
Transaction date
Sale
Price
3.38
Quantity 735 -15.5%
Value US$2,484
2.2
Firmani Lori Interim CFO Officer
Transaction date
Sale
Price
3.39
Quantity 147 -17.5%
Value US$498
1.7
Winslow Garrett General Counsel Officer
Transaction date
Sale
Price
3.39
Quantity 260 -15.4%
Value US$881
2.2
Firmani Lori Interim CFO Officer
Transaction date
Sale
Price
5.63
Quantity 261 -36.0%
Value US$1,469
1.3
Schambye Hans T. Chief Executive Officer Executive Director
Transaction date
Sale
Price
5.60
Quantity 1,341 -28.3%
Value US$7,510
1.7
Winslow Garrett General Counsel Officer
Transaction date
Sale
Price
5.60
Quantity 471 -31.8%
Value US$2,638
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
0.75
Quantity 535,534 -26.2%
Value US$401,650
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
0.75
Quantity 248,819 -28.3%
Value US$186,614
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
0.75
Quantity 38,327 -28.3%
Value US$28,745
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
3.00
Quantity 153,078 -6.8%
Value US$459,234
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
3.00
Quantity 29,700 -3.3%
Value US$89,100
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
3.00
Quantity 26,622 -16.4%
Value US$79,866
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
2.92
Quantity 26,700 -1.2%
Value US$77,964
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
2.92
Quantity 4,700 -0.5%
Value US$13,724
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
2.92
Quantity 7,800 -4.6%
Value US$22,776
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
2.40
Quantity 132,100 -5.5%
Value US$317,040
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
2.40
Quantity 52,800 -5.5%
Value US$126,720
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
2.40
Quantity 9,800 -5.5%
Value US$23,520
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.97
Quantity 8,878 -0.4%
Value US$17,490
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.97
Quantity 3,551 -0.4%
Value US$6,995
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.97
Quantity 660 -0.4%
Value US$1,300
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.86
Quantity 28,110 -1.1%
Value US$52,285
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.86
Quantity 11,245 -1.1%
Value US$20,916
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.86
Quantity 2,091 -1.1%
Value US$3,889
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.82
Quantity 9,459 -0.4%
Value US$17,215
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.82
Quantity 3,784 -0.4%
Value US$6,887
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.82
Quantity 703 -0.4%
Value US$1,279
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.81
Quantity 1,603 -0.1%
Value US$2,901
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.81
Quantity 641 -0.1%
Value US$1,160
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.81
Quantity 119 -0.1%
Value US$215
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.82
Quantity 9,459 -0.4%
Value US$17,215
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.82
Quantity 3,784 -0.4%
Value US$6,887
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.82
Quantity 703 -0.4%
Value US$1,279
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.79
Quantity 34,745 -1.4%
Value US$62,194
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.79
Quantity 13,899 -1.4%
Value US$24,879
2.6
ORBIMED ADVISORS LLC Large shareholder
Transaction date
Sale
Price
1.79
Quantity 2,584 -1.4%
Value US$4,625
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-06 2026-08-05 PrS Proposed sale
2.2
Firmani Lori

Officer

Officer
22,929
160.85
US$3,767,681 		22,929 160.85 US$3,767,681
2026-07-07 2026-07-06 S Sale
1.7
Winslow Garrett

General Counsel

Officer
28,644 -11.9%
404.16
US$4,525,686 		28,644 -11.9% 404.16 US$4,525,686
2026-06-22 2026-06-22 PrS Proposed sale
2.2
Firmani Lori

Officer

Officer
78,895
405.04
US$2,324,236 		78,895 405.04 US$2,324,236
2026-06-22 2026-06-22 PrS Proposed sale
2.2
Firmani Lori

Officer

Officer
7,615
25.36
US$193,140 		7,615 25.36 US$193,140
2026-01-06 2026-01-02 S Sale
1.3
Schambye Hans T.

Chief Executive Officer

Executive Director
700 -13.0%
21.38
US$14,966 		700 -13.0% 21.38 US$14,966
2026-01-06 2026-01-02 S Sale
2.2
Firmani Lori

Chief Financial Officer

Officer
135 -12.7%
21.41
US$2,890 		135 -12.7% 21.41 US$2,890
2026-01-06 2026-01-02 S Sale
1.7
Winslow Garrett

General Counsel

Officer
255 -12.1%
21.38
US$5,452 		255 -12.1% 21.38 US$5,452
2025-07-08 2025-07-03 S Sale
1.3
Schambye Hans T.

Chief Executive Officer

Executive Director
735 -15.5%
3.38
US$2,484 		735 -15.5% 3.38 US$2,484
2025-07-08 2025-07-03 S Sale
2.2
Firmani Lori

Interim CFO

Officer
147 -17.5%
3.39
US$498 		147 -17.5% 3.39 US$498
2025-07-08 2025-07-03 S Sale
1.7
Winslow Garrett

General Counsel

Officer
260 -15.4%
3.39
US$881 		260 -15.4% 3.39 US$881
2025-01-07 2025-01-03 S Sale
2.2
Firmani Lori

Interim CFO

Officer
261 -36.0%
5.63
US$1,469 		261 -36.0% 5.63 US$1,469
2025-01-07 2025-01-03 S Sale
1.3
Schambye Hans T.

Chief Executive Officer

Executive Director
1,341 -28.3%
5.60
US$7,510 		1,341 -28.3% 5.60 US$7,510
2025-01-07 2025-01-03 S Sale
1.7
Winslow Garrett

General Counsel

Officer
471 -31.8%
5.60
US$2,638 		471 -31.8% 5.60 US$2,638
2023-10-02 2023-10-02 PrS Proposed sale
The Biotech Growth Trust PLC

Shareholder
57,312
0.72
US$41,265 		57,312 0.72 US$41,265
2023-10-02 2023-10-02 PrS Proposed sale
OrbiMed Israel Partners II, L.P.

Shareholder
244,527
0.72
US$176,059 		244,527 0.72 US$176,059
2023-10-02 2023-10-02 PrS Proposed sale
2.6
OrbiMed Genesis Master Fund, L.P.

Shareholder
37,675
0.72
US$27,126 		37,675 0.72 US$27,126
2023-10-02 2023-10-02 PrS Proposed sale
2.6
OrbiMed Private Investments VII, LP

Shareholder
585,274
0.72
US$421,397 		585,274 0.72 US$421,397
2023-08-30 2023-08-30 PrS Proposed sale
The Biotech Growth Trust PLC

Shareholder
119,679
0.58
US$69,414 		119,679 0.58 US$69,414
2023-08-30 2023-08-30 PrS Proposed sale
OrbiMed Israel Partners II, L.P.

Shareholder
510,610
0.58
US$296,154 		510,610 0.58 US$296,154
2023-08-30 2023-08-30 PrS Proposed sale
2.6
OrbiMed Genesis Master Fund, L.P.

Shareholder
78,659
0.58
US$45,622 		78,659 0.58 US$45,622
2023-08-30 2023-08-30 PrS Proposed sale
2.6
OrbiMed Private Investments VII, LP

Shareholder
1,222,125
0.58
US$708,833 		1,222,125 0.58 US$708,833
2023-08-21 2023-08-21 PrS Proposed sale
2.6
OrbiMed Genesis Master Fund, L.P.

Shareholder
97,204
0.62
US$59,975 		97,204 0.62 US$59,975
2023-08-21 2023-08-21 PrS Proposed sale
2.6
OrbiMed Private Investments VII, LP

Shareholder
1,510,375
0.62
US$931,901 		1,510,375 0.62 US$931,901
2023-08-21 2023-08-21 PrS Proposed sale
The Biotech Growth Trust PLC

Shareholder
147,910
0.62
US$91,260 		147,910 0.62 US$91,260
2023-08-21 2023-08-21 PrS Proposed sale
OrbiMed Israel Partners II, L.P.

Shareholder
631,048
0.62
US$389,357 		631,048 0.62 US$389,357
2023-08-21 2023-08-15 PrS Proposed sale
2.6
OrbiMed Genesis Master Fund, L.P.

Shareholder
75,473
0.75
US$56,605 		75,473 0.75 US$56,605
2023-08-17 2023-08-15 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
535,534 -26.2%
0.75
US$401,650 		535,534 -26.2% 0.75 US$401,650
2023-08-17 2023-08-15 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
248,819 -28.3%
0.75
US$186,614 		248,819 -28.3% 0.75 US$186,614
2023-08-17 2023-08-15 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
38,327 -28.3%
0.75
US$28,745 		38,327 -28.3% 0.75 US$28,745
2023-08-15 2023-08-15 PrS Proposed sale
The Biotech Growth Trust PLC

Shareholder
114,843
0.75
US$86,132 		114,843 0.75 US$86,132
2023-08-15 2023-08-15 PrS Proposed sale
OrbiMed Israel Partners II, L.P.

Shareholder
489,970
0.75
US$367,478 		489,970 0.75 US$367,478
2023-08-15 2023-08-15 PrS Proposed sale
2.6
OrbiMed Private Investments VII, LP

Shareholder
1,172,714
0.75
US$879,536 		1,172,714 0.75 US$879,536
2023-08-15 2023-08-15 PrS Proposed sale
2.6
OrbiMed Genesis Master Fund, L.P.

Shareholder
75,473
0.75
US$56,605 		75,473 0.75 US$56,605
2023-08-02 2023-07-31 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
153,078 -6.8%
3.00
US$459,234 		153,078 -6.8% 3.00 US$459,234
2023-08-02 2023-07-31 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
29,700 -3.3%
3.00
US$89,100 		29,700 -3.3% 3.00 US$89,100
2023-08-02 2023-07-31 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
26,622 -16.4%
3.00
US$79,866 		26,622 -16.4% 3.00 US$79,866
2023-07-31 2023-07-31 PrS Proposed sale
The Biotech Growth Trust PLC

Shareholder
246,830
3.02
US$745,427 		246,830 3.02 US$745,427
2023-07-31 2023-07-31 PrS Proposed sale
OrbiMed Israel Partners II, L.P.

Shareholder
180,300
3.02
US$544,506 		180,300 3.02 US$544,506
2023-07-31 2023-07-31 PrS Proposed sale
2.6
OrbiMed Private Investments VII, LP

Shareholder
930,717
3.02
US$2,810,765 		930,717 3.02 US$2,810,765
2023-07-31 2023-07-31 PrS Proposed sale
2.6
OrbiMed Genesis Master Fund, L.P.

Shareholder
162,153
3.02
US$489,702 		162,153 3.02 US$489,702
2023-07-27 2023-07-25 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
26,700 -1.2%
2.92
US$77,964 		26,700 -1.2% 2.92 US$77,964
2023-07-27 2023-07-25 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
4,700 -0.5%
2.92
US$13,724 		4,700 -0.5% 2.92 US$13,724
2023-07-27 2023-07-25 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
7,800 -4.6%
2.92
US$22,776 		7,800 -4.6% 2.92 US$22,776
2023-07-25 2023-07-25 PrS Proposed sale
The Biotech Growth Trust PLC

Shareholder
8,100
2.35
US$19,035 		8,100 2.35 US$19,035
2023-07-25 2023-07-25 PrS Proposed sale
OrbiMed Israel Partners II, L.P.

Shareholder
4,700
2.35
US$11,045 		4,700 2.35 US$11,045
2023-07-25 2023-07-25 PrS Proposed sale
2.6
OrbiMed Private Investments VII, LP

Shareholder
26,700
2.35
US$62,745 		26,700 2.35 US$62,745
2023-07-25 2023-07-25 PrS Proposed sale
2.6
OrbiMed Genesis Master Fund, L.P.

Shareholder
7,800
2.35
US$18,330 		7,800 2.35 US$18,330
2023-07-17 2023-07-13 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
132,100 -5.5%
2.40
US$317,040 		132,100 -5.5% 2.40 US$317,040
2023-07-17 2023-07-13 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
52,800 -5.5%
2.40
US$126,720 		52,800 -5.5% 2.40 US$126,720
2023-07-17 2023-07-13 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
9,800 -5.5%
2.40
US$23,520 		9,800 -5.5% 2.40 US$23,520
2023-07-13 2023-07-13 PrS Proposed sale
OrbiMed Israel Partners II, L.P.

Shareholder
52,800
2.55
US$134,640 		52,800 2.55 US$134,640
2023-07-13 2023-07-13 PrS Proposed sale
The Biotech Growth Trust PLC

Shareholder
14,700
2.55
US$37,485 		14,700 2.55 US$37,485
2023-07-13 2023-07-13 PrS Proposed sale
2.6
OrbiMed Private Investments VII, LP

Shareholder
132,100
2.55
US$336,855 		132,100 2.55 US$336,855
2023-07-13 2023-07-13 PrS Proposed sale
2.6
OrbiMed Genesis Master Fund, L.P.

Shareholder
9,800
2.55
US$24,990 		9,800 2.55 US$24,990
2023-04-17 2023-04-17 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
8,878 -0.4%
1.97
US$17,490 		8,878 -0.4% 1.97 US$17,490
2023-04-17 2023-04-17 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
3,551 -0.4%
1.97
US$6,995 		3,551 -0.4% 1.97 US$6,995
2023-04-17 2023-04-17 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
660 -0.4%
1.97
US$1,300 		660 -0.4% 1.97 US$1,300
2023-04-17 2023-04-14 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
28,110 -1.1%
1.86
US$52,285 		28,110 -1.1% 1.86 US$52,285
2023-04-17 2023-04-14 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
11,245 -1.1%
1.86
US$20,916 		11,245 -1.1% 1.86 US$20,916
2023-04-17 2023-04-14 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
2,091 -1.1%
1.86
US$3,889 		2,091 -1.1% 1.86 US$3,889
2023-04-17 2023-04-13 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
9,459 -0.4%
1.82
US$17,215 		9,459 -0.4% 1.82 US$17,215
2023-04-17 2023-04-13 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
3,784 -0.4%
1.82
US$6,887 		3,784 -0.4% 1.82 US$6,887
2023-04-17 2023-04-13 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
703 -0.4%
1.82
US$1,279 		703 -0.4% 1.82 US$1,279
2023-04-12 2023-04-12 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
1,603 -0.1%
1.81
US$2,901 		1,603 -0.1% 1.81 US$2,901
2023-04-12 2023-04-12 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
641 -0.1%
1.81
US$1,160 		641 -0.1% 1.81 US$1,160
2023-04-12 2023-04-12 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
119 -0.1%
1.81
US$215 		119 -0.1% 1.81 US$215
2023-04-12 2023-04-11 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
9,459 -0.4%
1.82
US$17,215 		9,459 -0.4% 1.82 US$17,215
2023-04-12 2023-04-11 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
3,784 -0.4%
1.82
US$6,887 		3,784 -0.4% 1.82 US$6,887
2023-04-12 2023-04-11 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
703 -0.4%
1.82
US$1,279 		703 -0.4% 1.82 US$1,279
2023-04-12 2023-04-10 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
34,745 -1.4%
1.79
US$62,194 		34,745 -1.4% 1.79 US$62,194
2023-04-12 2023-04-10 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
13,899 -1.4%
1.79
US$24,879 		13,899 -1.4% 1.79 US$24,879
2023-04-12 2023-04-10 S Sale
2.6
ORBIMED ADVISORS LLC
Large shareholder
2,584 -1.4%
1.79
US$4,625 		2,584 -1.4% 1.79 US$4,625
2023-04-10 2023-04-10 PrS Proposed sale
2.6
OrbiMed Genesis Master Fund, L.P.

Shareholder
1,686
1.90
US$3,203 		1,686 1.90 US$3,203
2023-04-10 2023-04-10 PrS Proposed sale
The Biotech Growth Trust PLC

Shareholder
2,512
1.90
US$4,773 		2,512 1.90 US$4,773
2023-04-10 2023-04-10 PrS Proposed sale
OrbiMed Israel Partners II, L.P.

Shareholder
9,064
1.90
US$17,222 		9,064 1.90 US$17,222
Explore more

More insider trading research around Galecto Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America